Home › Amyotrophic Lateral Sclerosis › Georgia › Atlanta
Amyotrophic Lateral Sclerosis clinical trials in Atlanta, GA
8 studies for Amyotrophic Lateral Sclerosis are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
RecruitingPhase 3
- Emory University, Atlanta
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- Emory University, Atlanta
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
RecruitingPhase 2
- Zydus US007, Atlanta
Study of COYA 302 for the Treatment of ALS
RecruitingPhase 2/3
- Emory University, Atlanta
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
RecruitingObservational studyHealthy volunteers welcome
- Emory University, Atlanta
Tofersen in Non-SOD1 ALS
RecruitingPhase 2
- Emory University, Atlanta
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Recruiting
- Emory University School of Medicine, Atlanta
The National Amyotrophic Lateral Sclerosis Registry
RecruitingObservational study
- CDC, Atlanta
About Amyotrophic Lateral Sclerosis
ALS stands for Amyotrophic Lateral Sclerosis, also called Lou Gehrig's disease. ALS affects the nervous system, causing muscle problems. Find out how.
More about Amyotrophic Lateral Sclerosis on MedlinePlus
Amyotrophic Lateral Sclerosis trials in other cities
- Boston, MA19 studies
- Philadelphia, PA14 studies
- Jacksonville, FL13 studies
- Baltimore, MD13 studies
- New York City, NY11 studies
- Chicago, IL10 studies
- San Francisco, CA10 studies
- San Diego, CA10 studies
- St. Louis, MO9 studies
- Dallas, TX8 studies
- Phoenix, AZ8 studies
- Durham, NC7 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer47 studies
- Multiple Myeloma42 studies
- Breast Cancer41 studies
- Prostate Cancer33 studies
- Acute Myeloid Leukemia31 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Metastatic Cancer28 studies
- Major Depressive Disorder25 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.